Related Experiment Video
Updated: Jun 3, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Nutritional support and cardioprotection with L-carnitine: prescription appropriateness and safety concerns in
Leobardo Manuel Gómez-Oliván1, Analleli Valdés-Alanis, Lucila I Castro-Pastrana
1Laboratorio de Toxicología, Departamento de Farmacia, Facultad de Química, Universidad Autónoma del Estado de México, Paseo Tollocan esquina Paseo Colón. Col. Universidad. Toluca, Estado de México.
Insights
L-carnitine prescriptions in a neonatal intensive care unit (NICU) were often inappropriate, with incorrect dosing in over 60%. Adverse drug reactions, primarily gastrointestinal issues, were common, highlighting the need for a rational use policy.
Area of Science:
- Neonatal Medicine
- Clinical Pharmacy
- Pediatric Pharmacology
Background:
- Medication errors are a significant concern in neonatal care.
- L-carnitine is frequently used in Mexican NICUs for nutritional support and treating neonatal asphyxia-related cardiomyopathy.
Purpose of the Study:
- To evaluate the appropriateness of L-carnitine prescriptions in a Mexican NICU.
- To identify adverse drug reactions (ADRs) associated with L-carnitine therapy.
Main Methods:
- A longitudinal-retrospective study design was employed.
- Assessed L-carnitine prescriptions over a 12-month period.
- Collected and characterized ADR reports possibly related to L-carnitine.
Main Results:
- Only 18% of L-carnitine administrations were deemed appropriate.
- 60.7% of prescriptions had inappropriate doses outside recommended ranges.
- The overall ADR rate was 18.03%, with gastrointestinal issues (cramps, vomiting) being most frequent.
Conclusions:
- L-carnitine use in this NICU was largely inappropriate, particularly regarding dosing.
- Gastrointestinal adverse events were common with L-carnitine therapy.
- A rational use policy for L-carnitine is recommended for this NICU.
Abstract:
Medication errors are probably more common in neonates than is generally appreciated. In Mexican pediatric hospitals, L-carnitine is mainly used for nutritional support and to treat cardiomyopathy secondary to neonatal asphyxia. Using a longitudinal-retrospective approach we assessed the appropriateness of all L-carnitine prescriptions written during a 12-month period at a NICU of a second-level hospital located in Toluca, Mexico. Reports of adverse reactions possibly related to L-carnitine therapy were collected and characterized. Overall, administration of L-carnitine was considered justified and appropriate only in 18% of patients. 60.7% of L-carnitine prescriptions were rated as inappropriate because the prescribed doses fell outside the recommendations. The overall rate of ADRs calculated from the patient population was 18.03%. All of them were of gastrointestinal type: abdominal cramps (8 cases, 61.54%) and vomiting (5 cases, 38.46%). Our results supported the establishment of an L-carnitine rational use policy at the NICU of the hospital under study.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy VI: Nursing Management
Pharmacokinetics in Pediatric Patients: Drug Excretion
Myocarditis IV: Nursing Management
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
